Related Experiment Video
Updated: May 3, 2026
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions
Jurriaan M Peters1, Maxime Taquet2, Anna K Prohl1
1Department of Neurology & the Division of Epilepsy & Clinical Neurophysiology, Boston Children's Hospital, 300 Longwood Avenue, Fegan 9, Boston, MA 02115, USA ; Department of Radiology & the Computational Radiology Laboratory, Boston Children's Hospital, Boston, MA 02115, USA.
Diffusion tensor imaging (DTI) helps understand tuberous sclerosis complex (TSC) by characterizing brain microstructural changes. DTI aids in detecting epilepsy-causing tubers and may serve as a biomarker for neurocognitive outcomes in TSC research.
Area of Science:
- Neuroimaging
- Neurology
- Genetics
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder causing varied neurological issues like epilepsy and autism spectrum disorder.
- Noninvasive brain imaging is crucial for understanding TSC's complex pathology and comorbidities.
- Diffusion tensor imaging (DTI) offers insights into tissue microstructural properties.
Purpose of the Study:
- Introduce nonradiologists to DTI and its clinical/research applications in TSC.
- Highlight DTI's role in identifying epileptogenic tubers.
- Explore DTI's potential as a biomarker for TSC-related neurocognitive outcomes.
Main Methods:
- Diffusion tensor imaging (DTI) was used to model water diffusion in brain tissue.
- DTI measures were correlated with pathological changes in TSC.
- DTI findings were assessed for clinical and research relevance in TSC.
Main Results:
- DTI measures in TSC reflect known pathological changes.
- DTI can assist in detecting tubers associated with epilepsy.
- White matter DTI abnormalities correlate with neurocognitive issues like autism in TSC.
Conclusions:
- DTI is a valuable tool for both clinical and research aspects of tuberous sclerosis complex.
- DTI may serve as a biomarker for neurocognitive morbidity and treatment response in TSC.
- Further research with DTI could facilitate clinical trials for TSC treatments.
